News
Home  >  News > Researcher Carles Galdeano, Young Investigator Award 2019, sponsored by ‘Molecules’...

Researcher Carles Galdeano, Young Investigator Award 2019, sponsored by ‘Molecules’

Carles Galdeano, Serra Hunter professor and researcher at the Faculty of Pharmacy and Food Sciences.

Carles Galdeano, Serra Hunter professor and researcher at the Faculty of Pharmacy and Food Sciences.

18/05/2020

Recerca

Carles Galdeano, Serra Hunter professor and researcher at the Faculty of Pharmacy and Food Sciences, has been awarded the Young Investigator Award 2019, given by the journal Molecules to international researchers under the age of forty who make relevant contributions to the field of chemistry.

 

The award honours Carles Galdeano’s work in the field of protein degradation as a new strategy for the discovery of drugs, based on the use of small molecules able to remove unwanted specific proteins. This innovative technique helps to overcome many current barriers in the classic methodologies to find new therapies.

 

Carles Galdeano is a member of the Research Group of Computational Biology and Drug Design of the Institute of Biomedicine of the University of Barcelona (IBUB), and leads his own research group at the Faculty of Pharmacy and Food Sciences.

 

 

Graduated in Pharmacy at the University of Barcelona, where he obtained his doctoral degree in 2012, he did his postdoctoral studies at the universities of Cambridge and Dundee (United Kingdom), with funds from the European Commission Marie Curie, and received several national and international grants within the frame of his research activity (EMBO, Marie Curie and Beatriu de Pinós).  

 

Galdeano, member of the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, has been awarded with several prizes, such as the doctoral extraordinary award of the University of Barcelona in 2013, the Young Medicinal Chemist award in 2015, and his appointment to be in the 65th meeting of young nobel laureate researchers in Lindau (Germany) in 2015.

 

At the moment, Galdeano’s research is focused on the identification and characterization of new molecules able to interact with ligase E3 proteins and the study of the use of these enzymes to design new proteolysis targeting chimeras (PROTAC). Also, he is working on several collaboration projects to develop therapies in the field of cancer treatment and neurodegenerative diseases. 

 

Share this at:
| More |

Related information

  • Follow us:
  • Button to access University of Barcelona's Facebook profile
  • Button to access University of Barcelona's Twitter profile
  • Button to access University of Barcelona's Instagram profile
  • Button to access University of Barcelona's Linkedin profile
  • Button to access University of Barcelona's Youtube profile
  • Button to access University of Barcelona's Google+ profile
  • ??? peu.flickr.alt ???
Member of International recognition of excellence HR Excellence in Research logo del leru - League of European Research Universities logo del bkc - campus excel·lència logo del health universitat de barcelona campus

© Universitat de Barcelona